» Articles » PMID: 36173022

Uniqueness of Radiomic Features in Non-small Cell Lung Cancer

Overview
Date 2022 Sep 29
PMID 36173022
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The uniqueness of radiomic features, combined with their reproducibility, determines the reliability of radiomic studies. This study is to test the hypothesis that radiomic features extracted from a defined region of interest (ROI) are unique to the underlying structure (e.g., tumor).

Approach: Two cohorts of non-small cell lung cancer (NSCLC) patients were retrospectively retrieved from a GE and a Siemens CT scanner. The lung nodules (ROI) were delineated manually and radiomic features were extracted using IBEX. The same ROI was then translocated randomly to four other tissue regions of the same set of images: adipose, heart, lung beyond nodule, and muscle for radiomic feature extraction. Coefficient of variation (CV) within different ROIs and concordance correlation coefficient (CCC) between lung nodule and a given tissue region were calculated to test to determine feature uniqueness. The radiomic features were considered nonunique when (1) the CV < 10% and CCC > 0.85 for over 50% of patients; and (2) the CCC > 0.85 appeared in ≥2 tissue regions beyond the defined region.

Results: In total, 14 patients from GE and 18 patients from Siemens are analyzed. The results show that 12 features fall below the 10% CV threshold for over 50% of patients in the GE cohort and 29 features in the Siemens cohort. According to CCC, 18 radiomic features in GE and 16 features in Siemens are identified as nonunique, with 11 overlapping features. Combining CV and CCC, 9 of 123 calculated features (7.3%) are identified as nonunique to a defined ROI.

Conclusions: Radiomic feature uniqueness should be considered to improve the reliability of radiomics study.

Citing Articles

Mitigating the impact of image processing variations on tumour [F]-FDG-PET radiomic feature robustness.

Ramlee S, Manavaki R, Aloj L, Escudero Sanchez L Sci Rep. 2024; 14(1):16294.

PMID: 39009706 PMC: 11251269. DOI: 10.1038/s41598-024-67239-8.


Uniqueness of radiomic features in non-small cell lung cancer.

Ge G, Zhang J J Appl Clin Med Phys. 2022; 23(12):e13787.

PMID: 36173022 PMC: 9797180. DOI: 10.1002/acm2.13787.

References
1.
Ge G, Zhang J . Uniqueness of radiomic features in non-small cell lung cancer. J Appl Clin Med Phys. 2022; 23(12):e13787. PMC: 9797180. DOI: 10.1002/acm2.13787. View

2.
El Naqa I, Kerns S, Coates J, Luo Y, Speers C, West C . Radiogenomics and radiotherapy response modeling. Phys Med Biol. 2017; 62(16):R179-R206. PMC: 5557376. DOI: 10.1088/1361-6560/aa7c55. View

3.
Balagurunathan Y, Gu Y, Wang H, Kumar V, Grove O, Hawkins S . Reproducibility and Prognosis of Quantitative Features Extracted from CT Images. Transl Oncol. 2014; 7(1):72-87. PMC: 3998690. DOI: 10.1593/tlo.13844. View

4.
Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X . The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019; 9(5):1303-1322. PMC: 6401507. DOI: 10.7150/thno.30309. View

5.
Parekh V, Jacobs M . Radiomics: a new application from established techniques. Expert Rev Precis Med Drug Dev. 2017; 1(2):207-226. PMC: 5193485. DOI: 10.1080/23808993.2016.1164013. View